Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


10.04.2017

1 Acta Ophthalmol
1 Am J Clin Nutr
2 Am J Epidemiol
1 Am J Manag Care
1 Angiology
2 Ann Intern Med
1 Atherosclerosis
1 BMJ
1 Circ Cardiovasc Interv
3 Circulation
5 Diabet Med
1 Diabetes
1 Diabetes Care
7 Diabetes Obes Metab
7 Diabetologia
2 Hypertension
4 J Clin Endocrinol Metab
1 J Clin Invest
2 J Diabetes Complications
1 J Immunol
1 Kidney Int
5 Lancet Diabetes Endocrinol
2 Pediatr Diabetes
12 PLoS One
1 Retina
1 Stroke


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Ophthalmol

  1. LIN S, Gupta B, James N, Ling RH, et al
    Visual impairment certification due to diabetic retinopathy in North and Eastern Devon.
    Acta Ophthalmol. 2017 Apr 1. doi: 10.1111/aos.13400.
    PubMed     Text format     Abstract available


    Am J Clin Nutr

  2. CHEN GC, Zhang Z, van Dam RM, Qin LQ, et al
    Nonlinear relation between animal protein intake and risk of type 2 diabetes: a dose-response meta-analysis of prospective studies.
    Am J Clin Nutr. 2017;105:1014-1016.
    PubMed     Text format    


    Am J Epidemiol

  3. LARAIA BA, Downing JM, Zhang YT, Dow WH, et al
    Food Environment and Weight Change: Does Residential Mobility Matter?: The Diabetes Study of Northern California (DISTANCE).
    Am J Epidemiol. 2017 Apr 6:1-8. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. READ SH, Lewis SC, Halbesma N, Wild SH, et al
    Measuring the Association Between Body Mass Index and All-Cause Mortality in the Presence of Missing Data: Analyses From the Scottish National Diabetes Register.
    Am J Epidemiol. 2017 Mar 22:1-9. doi: 10.1093.
    PubMed     Text format     Abstract available


    Am J Manag Care

  5. GOFF SL, Murphy L, Knee AB, Guhn-Knight H, et al
    Effects of an enhanced primary care program on diabetes outcomes.
    Am J Manag Care. 2017;23:e75-e81.
    PubMed     Text format     Abstract available


    Angiology

  6. SPANOS K, Saleptsis V, Athanasoulas A, Karathanos C, et al
    Re: "Prognostic Factors in Diabetic Foot Ulcer".
    Angiology. 2017 Jan 1:3319717700971. doi: 10.1177/0003319717700971.
    PubMed     Text format    


    Ann Intern Med

  7. PETERSEN MP, Ratner RE
    Should We Screen for Type 2 Diabetes?
    Ann Intern Med. 2017;166:535.
    PubMed     Text format    

  8. RIND DM
    Should We Screen for Type 2 Diabetes?
    Ann Intern Med. 2017;166:535-536.
    PubMed     Text format    


    Atherosclerosis

  9. MOH MC, Sum CF, Tavintharan S, Ang K, et al
    Baseline predictors of aortic stiffness progression among multi-ethnic Asians with type 2 diabetes.
    Atherosclerosis. 2017;260:102-109.
    PubMed     Text format     Abstract available


    BMJ

  10. MAYOR S
    Injections with structured diabetes education are as good as pumps, trial shows.
    BMJ. 2017;357:j1667.
    PubMed     Text format    


    Circ Cardiovasc Interv

  11. HWANG JK, Lee SH, Song YB, Ahn J, et al
    Glycemic Control Status After Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients With Type 2 Diabetes Mellitus.
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format     Abstract available


    Circulation

  12. TSUDA K
    Letter by Tsuda Regarding Article, "Prediabetes and Type 2 Diabetes Are Associated With Generalized Microvascular Dysfunction: The Maastricht Study".
    Circulation. 2017;135:e858-e859.
    PubMed     Text format    

  13. BRZEZINSKI RY, Berliner S, Shenhar-Tsarfaty S
    Letter by Brzezinski et al Regarding Article, "Prediabetes and Type 2 Diabetes Are Associated With Generalized Microvascular Dysfunction: The Maastricht Study".
    Circulation. 2017;135:e860-e861.
    PubMed     Text format    

  14. SORENSEN BM, Houben AJ, Martens RJ, Stehouwer CD, et al
    Response by Sorensen et al to Letters Regarding Article, "Prediabetes and Type 2 Diabetes Are Associated With Generalized Microvascular Dysfunction: The Maastricht Study".
    Circulation. 2017;135:e862-e863.
    PubMed     Text format    


    Diabet Med

  15. BARR EL, Cunningham J, Tatipata S, Dunbar T, et al
    Associations of mortality and cardiovascular disease risks with diabetes and albuminuria in urban Indigenous Australians: the DRUID follow-up study.
    Diabet Med. 2017 Apr 4. doi: 10.1111/dme.13360.
    PubMed     Text format     Abstract available

  16. ZHOU L, Yang L, Zhou X, Lv X, et al
    A comparison of HbA1c concentration in people with Type 2 diabetes at sea level and high altitude in China: an observational study.
    Diabet Med. 2017 Mar 28. doi: 10.1111/dme.13356.
    PubMed     Text format     Abstract available

  17. IBANEZ-BRURON MC, Solebo AL, Cumberland PM, Rahi JS, et al
    Screening for diabetic retinopathy in children and young people in the UK: potential gaps in ascertainment of those at risk.
    Diabet Med. 2017 Apr 4. doi: 10.1111/dme.13361.
    PubMed     Text format     Abstract available

  18. CAPEHORN M, Polonsky WH, Edelman S, Belton A, et al
    Challenges faced by physicians when discussing the Type 2 diabetes diagnosis with patients: insights from a cross-national study (IntroDia(R) ).
    Diabet Med. 2017 Mar 28. doi: 10.1111/dme.13357.
    PubMed     Text format     Abstract available

  19. ONG YH, Koh WC, Ng ML, Tam ZY, et al
    Glutamic acid decarboxylase and islet antigen 2 antibody profiles in people with adult-onset diabetes mellitus: a comparison between mixed ethnic populations in Singapore and Germany.
    Diabet Med. 2017 Mar 28. doi: 10.1111/dme.13358.
    PubMed     Text format     Abstract available


    Diabetes

  20. MATSUI T, Higashimoto Y, Nishino Y, Nakamura N, et al
    RAGE-aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.
    Diabetes. 2017 Apr 6. pii: db161281. doi: 10.2337/db16-1281.
    PubMed     Text format     Abstract available


    Diabetes Care

  21. MARCHAND L, Luigi P, Place J, Dalla-Vale F, et al
    Improvement of Glucose Control and Reduction of Hypoglycemia Following Intravenous Immune Globulins in a Child With Type 1 Diabetes and High Levels of Insulin Antibodies.
    Diabetes Care. 2017 Apr 6. pii: dc162420. doi: 10.2337/dc16-2420.
    PubMed     Text format    


    Diabetes Obes Metab

  22. WYSHAM C, Bonadonna RC, Aroda VR, Puig-Domingo M, et al
    Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) versus insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLa
    Diabetes Obes Metab. 2017 Apr 6. doi: 10.1111/dom.12961.
    PubMed     Text format     Abstract available

  23. METZGER M, Castaneda J, Reznik Y, Giorgino F, et al
    Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: an analysis from the OpT2mise randomized trial.
    Diabetes Obes Metab. 2017 Apr 4. doi: 10.1111/dom.12960.
    PubMed     Text format     Abstract available

  24. ZGHEBI SS, Steinke DT, Carr MJ, Rutter MK, et al
    Examining Trends in Type 2 Diabetes Incidence, Prevalence and Mortality in the UK between 2004 and 2014.
    Diabetes Obes Metab. 2017 Apr 7. doi: 10.1111/dom.12964.
    PubMed     Text format     Abstract available

  25. CHILTON R, Tikkanen I, Hehnke U, Woerle HJ, et al
    Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension.
    Diabetes Obes Metab. 2017 Apr 6. doi: 10.1111/dom.12962.
    PubMed     Text format     Abstract available

  26. RUAN Y, Thabit H, Leelarathna L, Hartnell S, et al
    Faster insulin action is associated with improved glycemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes.
    Diabetes Obes Metab. 2017 Mar 30. doi: 10.1111/dom.12956.
    PubMed     Text format     Abstract available

  27. TERAUCHI Y, Tamura M, Senda M, Gunji R, et al
    Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J-STEP/INS): Results of a 16 week randomized, double-blind, placebo-controlled multicentre trial.
    Diabetes Obes Metab. 2017 Mar 30. doi: 10.1111/dom.12957.
    PubMed     Text format     Abstract available

  28. GUZMAN CB, Zhang XM, Liu R, Regev A, et al
    Treatment with LY2409021, a Glucagon Receptor Antagonist, Increases Liver Fat in Patients with Type 2 Diabetes.
    Diabetes Obes Metab. 2017 Mar 31. doi: 10.1111/dom.12958.
    PubMed     Text format     Abstract available


    Diabetologia

  29. GURKA MJ, Golden SH, Musani SK, Sims M, et al
    Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study.
    Diabetologia. 2017 Apr 4. doi: 10.1007/s00125-017-4267.
    PubMed     Text format     Abstract available

  30. FOGHSGAARD S, Vedtofte L, Andreasen C, Andersen ES, et al
    Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect.
    Diabetologia. 2017 Mar 31. doi: 10.1007/s00125-017-4265.
    PubMed     Text format     Abstract available

  31. BERK KA, Yahya R, Verhoeven AJ, Touw J, et al
    Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes.
    Diabetologia. 2017 Apr 6. doi: 10.1007/s00125-017-4246.
    PubMed     Text format     Abstract available

  32. VAN DIEPEN JA, Robben JH, Hooiveld GJ, Carmone C, et al
    SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes.
    Diabetologia. 2017 Apr 5. doi: 10.1007/s00125-017-4261.
    PubMed     Text format     Abstract available

  33. SKRTIC M, Yang GK, Perkins BA, Soleymanlou N, et al
    Erratum to: Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration.
    Diabetologia. 2017 Apr 3. doi: 10.1007/s00125-017-4241.
    PubMed     Text format    

  34. POLLANEN PM, Lempainen J, Laine AP, Toppari J, et al
    Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Diabetologia. 2017 Mar 31. doi: 10.1007/s00125-017-4258.
    PubMed     Text format     Abstract available

  35. ZANCHI C, Macconi D, Trionfini P, Tomasoni S, et al
    MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
    Diabetologia. 2017 Mar 31. doi: 10.1007/s00125-017-4248.
    PubMed     Text format     Abstract available


    Hypertension

  36. STARUSCHENKO A
    Hypertension and Diabetes Mellitus: The Chicken and Egg Problem.
    Hypertension. 2017 Apr 3. pii: HYPERTENSIONAHA.117.08671.
    PubMed     Text format    

  37. LEE H, Dominiczak AF, Jennings GL, Cho EJ, et al
    Case of Chronic Indolent Pheochromocytoma That Caused Medically Controlled Hypertension but Treatment-Resistant Diabetes Mellitus.
    Hypertension. 2017 Apr 3. pii: HYPERTENSIONAHA.117.09183.
    PubMed     Text format    


    J Clin Endocrinol Metab

  38. YIN T, Kuo SC, Chang YY, Chen YT, et al
    Verapamil Use is Associated with Reduction of Newly Diagnosed Diabetes Mellitus.
    J Clin Endocrinol Metab. 2017 Mar 24. doi: 10.1210/jc.2016-3778.
    PubMed     Text format     Abstract available

  39. COURTADE JA, Klimek-Abercrombie AM, Chen YC, Patel N, et al
    Measurement of pro-islet amyloid polypeptide (1-48) in diabetes and islet transplants.
    J Clin Endocrinol Metab. 2017 Mar 24. doi: 10.1210/jc.2016-2773.
    PubMed     Text format     Abstract available

  40. JONSDOTTIR B, Larsson C, Carlsson A, Forsander G, et al
    Thyroid and Islet Autoantibodies Predict Autoimmune Thyroid Disease at Type 1 Diabetes Diagnosis.
    J Clin Endocrinol Metab. 2017;102:1277-1285.
    PubMed     Text format     Abstract available

  41. FAIENZA MF, Ventura A, Delvecchio M, Fusillo A, et al
    High Sclerostin and Dickkopf-1 (DKK-1) Serum Levels in Children and Adolescents With Type 1 Diabetes Mellitus.
    J Clin Endocrinol Metab. 2017;102:1174-1181.
    PubMed     Text format     Abstract available


    J Clin Invest

  42. BI X, Li F, Liu S, Jin Y, et al
    omega-3 polyunsaturated fatty acids ameliorate type 1 diabetes and autoimmunity.
    J Clin Invest. 2017 Apr 4. pii: 87388. doi: 10.1172/JCI87388.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  43. OBADAN NO, Walker RJ, Egede LE
    Independent correlates of chronic kidney disease awareness among adults with type 2 diabetes.
    J Diabetes Complications. 2017 Mar 18. pii: S1056-8727(16)30910.
    PubMed     Text format     Abstract available

  44. LAKE AJ, Browne JL, Rees G, Speight J, et al
    What factors influence uptake of retinal screening among young adults with type 2 diabetes? A qualitative study informed by the theoretical domains framework.
    J Diabetes Complications. 2017 Mar 14. pii: S1056-8727(16)30935.
    PubMed     Text format     Abstract available


    J Immunol

  45. FORSBERG MH, Ciecko AE, Bednar KJ, Itoh A, et al
    CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD Mice.
    J Immunol. 2017 Mar 31. pii: 1601851. doi: 10.4049/jimmunol.1601851.
    PubMed     Text format     Abstract available


    Kidney Int

  46. KROLEWSKI AS, Skupien J, Rossing P, Warram JH, et al
    Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.
    Kidney Int. 2017 Mar 30. pii: S0085-2538(17)30081.
    PubMed     Text format     Abstract available


    Lancet Diabetes Endocrinol

  47. AHREN B, Masmiquel L, Kumar H, Sargin M, et al
    Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.
    Lancet Diabetes Endocrinol. 2017 Apr 3. pii: S2213-8587(17)30092.
    PubMed     Text format     Abstract available

  48. MADSBAD S, Holst JJ
    Glycaemic control and weight loss with semaglutide in type 2 diabetes.
    Lancet Diabetes Endocrinol. 2017 Apr 3. pii: S2213-8587(17)30094.
    PubMed     Text format    

  49. DHATARIYA KK, Umpierrez GE
    Guidelines for management of diabetic ketoacidosis: time to revise?
    Lancet Diabetes Endocrinol. 2017 Mar 31. pii: S2213-8587(17)30093.
    PubMed     Text format    

  50. ZOUNGAS S, Arima H, Gerstein HC, Holman RR, et al
    Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials.
    Lancet Diabetes Endocrinol. 2017 Mar 29. pii: S2213-8587(17)30104.
    PubMed     Text format     Abstract available


  51. Correction to Lancet Diabetes Endocrinol 2017; published online Jan 25. http://dx.doi.org/10.1016/S2213-8587(17)30033-5.
    Lancet Diabetes Endocrinol. 2017 Apr 3. pii: S2213-8587(17)30106.
    PubMed     Text format    


    Pediatr Diabetes

  52. SHARWOOD EF, Hughes IP, Pretorius CJ, Trnka P, et al
    Therapeutic plasma exchange normalizes insulin-mediated response in a child with type 1 diabetes and insulin autoimmune syndrome.
    Pediatr Diabetes. 2017 Mar 29. doi: 10.1111/pedi.12522.
    PubMed     Text format     Abstract available

  53. KRISKA A, El Ghormli L, Copeland KC, Higgins J, et al
    Impact of lifestyle behavior change on glycemic control in youth with type 2 diabetes.
    Pediatr Diabetes. 2017 Apr 4. doi: 10.1111/pedi.12526.
    PubMed     Text format     Abstract available


    PLoS One

  54. LLAURADO G, Cano A, Hernandez C, Gonzalez-Sastre M, et al
    Type 1 diabetes: Developing the first risk-estimation model for predicting silent myocardial ischemia. The potential role of insulin resistance.
    PLoS One. 2017;12:e0174640.
    PubMed     Text format     Abstract available

  55. DARIO A, Ferreira M, Refshauge K, Harmer A, et al
    Mapping the association between back pain and type 2 diabetes: A cross-sectional and longitudinal study of adult Spanish twins.
    PLoS One. 2017;12:e0174757.
    PubMed     Text format     Abstract available

  56. AL-MRABEH A, Hollingsworth KG, Steven S, Tiniakos D, et al
    Quantification of intrapancreatic fat in type 2 diabetes by MRI.
    PLoS One. 2017;12:e0174660.
    PubMed     Text format     Abstract available

  57. BELINOVA L, Kahleova H, Malinska H, Topolcan O, et al
    The effect of meal frequency in a reduced-energy regimen on the gastrointestinal and appetite hormones in patients with type 2 diabetes: A randomised crossover study.
    PLoS One. 2017;12:e0174820.
    PubMed     Text format     Abstract available

  58. WAUGH K, Snell-Bergeon J, Michels A, Dong F, et al
    Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).
    PLoS One. 2017;12:e0174840.
    PubMed     Text format     Abstract available

  59. VANROY J, Seghers J, Bogaerts A, Devloo K, et al
    Short- and long-term effects of a need-supportive physical activity intervention among patients with type 2 diabetes mellitus: A randomized controlled pilot trial.
    PLoS One. 2017;12:e0174805.
    PubMed     Text format     Abstract available

  60. FARRAR D, Simmonds M, Bryant M, Lawlor DA, et al
    Risk factor screening to identify women requiring oral glucose tolerance testing to diagnose gestational diabetes: A systematic review and meta-analysis and analysis of two pregnancy cohorts.
    PLoS One. 2017;12:e0175288.
    PubMed     Text format     Abstract available

  61. YANG YW, Liu HH, Lin TH, Chuang HY, et al
    Association between different anticholinergic drugs and subsequent dementia risk in patients with diabetes mellitus.
    PLoS One. 2017;12:e0175335.
    PubMed     Text format     Abstract available

  62. DAIMON M, Kamba A, Murakami H, Mizushiri S, et al
    Association between serum prolactin levels and insulin resistance in non-diabetic men.
    PLoS One. 2017;12:e0175204.
    PubMed     Text format     Abstract available

  63. DAMANTI S, Bourron O, Doulazmi M, Mandengue Sosso AL, et al
    Relationship between sleep parameters, insulin resistance and age-adjusted insulin like growth factor-1 score in non diabetic older patients.
    PLoS One. 2017;12:e0174876.
    PubMed     Text format     Abstract available

  64. PATSCH JM, Rasul S, Huber FA, Leitner K, et al
    Similarities in trabecular hypertrophy with site-specific differences in cortical morphology between men and women with type 2 diabetes mellitus.
    PLoS One. 2017;12:e0174664.
    PubMed     Text format     Abstract available

  65. HWANG DJ, Lee KM, Park MS, Choi SH, et al
    Association between diabetic foot ulcer and diabetic retinopathy.
    PLoS One. 2017;12:e0175270.
    PubMed     Text format     Abstract available


    Retina

  66. HAFNER J, Prager S, Lammer J, Kriechbaum K, et al
    COMPARISON OF GANGLION CELL INNER PLEXIFORM LAYER THICKNESS BY CIRRUS AND SPECTRALIS OPTICAL COHERENCE TOMOGRAPHY IN DIABETIC MACULAR EDEMA.
    Retina. 2017 Apr 3. doi: 10.1097/IAE.0000000000001631.
    PubMed     Text format     Abstract available


    Stroke

  67. ZINMAN B, Inzucchi SE, Lachin JM, Wanner C, et al
    Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk.
    Stroke. 2017 Apr 6. pii: STROKEAHA.116.015756. doi: 10.1161/STROKEAHA.116.015756
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: